Efficacy of Pembrolizumab and Lenvatinib in Patients With Anaplastic Thyroid Cancer
Conditions: Anaplastic Thyroid Cancer Interventions: Drug: Pembrolizumab + Lenvatinib Sponsors: Saint Petersburg State University, Russia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
A Study of RO7617991 in Patients With Locally Advanced or Metastatic MAGE-A4-Positive Solid Tumors
Conditions: Refractory Cancer; Recurrent Cancer; Solid Tumor, Adult Interventions: Drug: RO7617991; Drug: Tocilizumab Sponsors: Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Metronomic Chemotherapy in a Real-world Population of Advanced Breast Cancer Patients
Conditions: Breast Cancer Interventions: Drug: cyclophosphamide , methotrexate , vinorelbine ,capecitabine Sponsors: Sun Yat-sen University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
BiVictriX Announces FDA Orphan Drug Designation and Completion of FDA INTERACT Meeting for BVX001 in the Treatment of Acute Myeloid Leukemia
Alderley Park, 17 April 2024– BiVictriX Therapeutics plc (AIM: BVX), a biotechnology company developing novel, next-generation bispecific Antibody Drug Conjugates (bxADCs) which are designed to offer substantially improved cancer cell... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - April 17, 2024 Category: Pharmaceuticals Source Type: clinical trials
U/S Guided Transversus Thoracic and Pectoral Nerve Block Versus Pectoral Nerve Block in MRM
Conditions: Breast Cancer; Analgesia Interventions: Procedure: Transeversus Thoracic Plane Block (TTPB) and Pectoral Nerves (PECS) Block; Procedure: Pectoral Nerves (PECS) Block Sponsors: Ahmed Mohamed Soliman Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib
Conditions: Non-small Cell Lung Cancer Interventions: Drug: Trilaciclib Sponsors: Henan Cancer Hospital; Jiangsu Simcere Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Ex-vivo Ultrasound Guided Radiofrequency Ablation on Pancreatic Solid Lesions
Conditions: Pancreatic Cancer; Endoscopic Ultrasound; Radiofrequency Ablation Interventions: Procedure: ex-vivo RFA under US control at 10 Watts (W) of power in 3 differents arms of lesions; Procedure: ex-vivo RFA under US control at 30 Watts (W) of power in 3 differents arms of lesions; Procedure: ex-vivo RFA under US control at 50 Watts (W) of power in 3 differents arms of lesions Sponsors: IRCCS San Raffaele Terminated (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
First-line Treatment for Unresectable Locally Advanced Distal Cholangiocarcinoma Combining Radiotherapy and HAIC
Conditions: Intrahepatic Cholangiocarcinoma Interventions: Radiation: Radiotherapy; Drug: HAIC (GEMOX); Drug: Chemotherapy Sponsors: Shandong Cancer Hospital and Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Serplulimab Combined With Bevacizumab Biosimilar and HAIC in Advanced Hepatocellular Carcinoma (HCC) Patients
Conditions: Advanced Hepatocellular Carcinoma Interventions: Drug: HAIC+Serplulimab （HLX10）+ Bevacizumab Biosimilar（HLX04） Sponsors: Tianjin Medical University Cancer Institute and Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Newly Emerging Immunotherapy for Pancreatic Cancer Treatment
Conditions: Pancreatic Cancer Interventions: Drug: JS001; Drug: JS004; Drug: JS007; Drug: JS015; Drug: Irinotecan Liposome Injection; Drug: 5-Fluorouracil (5-FU); Drug: Leucovorin (LV); Drug: Nab paclitaxel; Drug: Gemcitabine Sponsors: Fudan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Correlation Between the Analgesic Effect of Fentanyl Transdermal Patches and Nutritional Status in Cancer Pain Patients
Conditions: Cancer Pain; Nutrition Disorders Interventions: Drug: transdermal fentanyl Sponsors: Chongqing University Cancer Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
A Randomized Controlled Trial of the Safety and Efficacy of Robotic Telesurgery Versus Laparoscopic Surgery
Conditions: Liver Cancer; Renal Cancer; Rectal Cancer Interventions: Procedure: Robotic telesurgery; Procedure: Laparoscopic surgery Sponsors: Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Trial for Treatment of High Risk BC With Two Sequences of Neoadjuvant Chemotherapy With Pembrolizumab
Conditions: Early Breast Cancer; Triple Negative Breast Cancer Interventions: Drug: Pembrolizumab injection Sponsors: Fundacao Champalimaud Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Collection of Biological Specimens and Associated Health Information
Conditions: Cancer; Other Disease Sponsors: Ovation.io, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
The Effectiveness of Bupivacaine and Bupivacaine+Dexmedetomidine Combination in Transversus Abdominis Plane* Block
Conditions: Colorectal Cancer; Colorectal Neoplasms Interventions: Drug: Bupivacain; Drug: bupivacain+dexmedetomidine Sponsors: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
